NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
22/08/2023
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
NOCTURNAL
ST13
US500000097175653Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Primeiro uso
Primeiro uso no comércio
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Devon E. White WYRICK ROBBINS YATES & PONTON LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
business consulting services, namely, providing assistance in the development of innovation-driven business strategies and creative ideation; business consulting in the field of clinical trials, namely, assisting with clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies; business consulting services, namely, providing information to companies and universities on managing grant funding from federal, state, and local governments for clinical research and clinical trials; business consulting services, namely, maintaining design history files, performing business risk analysis, and planning and executing verification and validation activities that support clinical investigations in domestic and international settings, namely, providing independent review of clinical trials for business purposes, developing regulatory strategies for obtaining domestic and international approvals in the nature of clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with applications for drug and medical device approval, and assisting businesses in preparing and filing applications for and managing government grant funding in the field of medical devices and products; business consulting services, namely, assisting with clinical trial submissions, namely, regulatory submission management, namely, assisting others in preparing and filing applications for new drugs and new medical devices with governmental regulatory bodies; business consulting services, namely, assisting in obtaining domestic and international approvals by developing regulatory strategies and authoring product approval and product registration submissions; business consulting services, namely, project management services to identify and mitigate potential risks in complex projects; business consulting services, namely, consultation in the fields of medical products and medical devices
Classe 36
business financial and funding consulting services, namely, providing information that advises companies and universities seeking to obtain grant funding from federal, state, and local governments for clinical research and clinical trials
Classe 42
product research and development in the fields of medical products and medical devices; mechanical engineering services for electronics packaging, structural finite element analysis, and thermal analysis; product design and development in the field of medical devices, namely, developing extensive analog circuitry, digital circuitry, embedded firmware, and application software to meet the demands of medical products and medical devices; product design and development in the field of medical devices, namely, electromagnetic compatibility (EMC) and electrical safety testing to meet the demands of international regulatory standards; product design and development in the field of medical products and medical devices, namely, development of laser systems, fiber and electro-optics, and biophotonics for spectroscopy and optical characterization of living tissue via both diffuse reflectance and fluorescence; cloud-based Platform as a Service (PaaS) featuring computer software platforms that communicate with and collect data from medical products and medical devices; product design and development in the field of medical products and medical devices, namely, developing extensive analog circuitry, digital circuitry, embedded firmware, and application software for use with medical products and medical devices including topical electronic medical devices, active electronic implants, implantable pacemakers, defibrillators, diagnostic catheters, ablation catheters, and neurostimulators; business product development consulting services, namely, providing assistance in the development of leading-edge technologies for medical, biopharmaceutical, and biotechnology companies
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
NOTICE OF REGISTRATION CONFIRMATION EMAILED
22/08/2023
REGISTERED-PRINCIPAL REGISTER
22/08/2023
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/06/2023
PUBLISHED FOR OPPOSITION
06/06/2023
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/05/2023
APPROVED FOR PUB - PRINCIPAL REGISTER
03/05/2023
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2023
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/04/2023
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/04/2023
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/04/2023
NON-FINAL ACTION E-MAILED
07/04/2023
NON-FINAL ACTION WRITTEN
07/04/2023
TEAS/EMAIL CORRESPONDENCE ENTERED
07/03/2023
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/03/2023
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/03/2023
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/12/2022
NON-FINAL ACTION E-MAILED
22/12/2022
NON-FINAL ACTION WRITTEN
22/12/2022
TEAS/EMAIL CORRESPONDENCE ENTERED
23/11/2022
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/11/2022
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/11/2022
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/09/2022
NON-FINAL ACTION E-MAILED
26/09/2022
NON-FINAL ACTION WRITTEN
26/09/2022
ASSIGNED TO EXAMINER
22/09/2022
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/12/2021
NEW APPLICATION ENTERED
20/12/2021
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.